382 related articles for article (PubMed ID: 22171125)
21. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
[TBL] [Abstract][Full Text] [Related]
22. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
Han YF; Zhao J; Ma LY; Yin JH; Chang WJ; Zhang HW; Cao GW
World J Gastroenterol; 2011 Oct; 17(38):4258-70. PubMed ID: 22090781
[TBL] [Abstract][Full Text] [Related]
23. Distinct Patterns of HBV Integration and
Jang JW; Kim HS; Kim JS; Lee SK; Han JW; Sung PS; Bae SH; Choi JY; Yoon SK; Han DJ; Kim TM; Roberts LR
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209079
[TBL] [Abstract][Full Text] [Related]
24. Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.
Studach LL; Menne S; Cairo S; Buendia MA; Hullinger RL; Lefrançois L; Merle P; Andrisani OM
Hepatology; 2012 Oct; 56(4):1240-51. PubMed ID: 22505317
[TBL] [Abstract][Full Text] [Related]
25. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus X gene and hepatocarcinogenesis.
Ng SA; Lee C
J Gastroenterol; 2011 Aug; 46(8):974-90. PubMed ID: 21647825
[TBL] [Abstract][Full Text] [Related]
28. Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.
Hai H; Tamori A; Kawada N
World J Gastroenterol; 2014 May; 20(20):6236-43. PubMed ID: 24876744
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of hepatitis B virus-associated liver cancer.
Rabe C; Cheng B; Caselmann WH
Dig Dis; 2001; 19(4):279-87. PubMed ID: 11935087
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma and the underlying mechanisms.
Oyagbemi AA; Azeez OI; Saba AB
Afr Health Sci; 2010 Mar; 10(1):93-8. PubMed ID: 20811532
[TBL] [Abstract][Full Text] [Related]
31. The Biological Function of Hepatitis B Virus X Protein in Hepatocellular Carcinoma.
Xu Q; Gu S; Liang J; Lin Z; Zheng S; Yan J
Oncol Res; 2019 Mar; 27(4):509-514. PubMed ID: 29891022
[TBL] [Abstract][Full Text] [Related]
32. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
33. Molecular aspects of hepatitis B viral infection and the viral carcinogenesis.
Ryu WS
J Biochem Mol Biol; 2003 Jan; 36(1):138-43. PubMed ID: 12542984
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B x antigen and p53 in the development of hepatocellular carcinoma.
Feitelson MA
J Hepatobiliary Pancreat Surg; 1998; 5(4):367-74. PubMed ID: 9931385
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma.
Buendia MA; Neuveut C
Cold Spring Harb Perspect Med; 2015 Feb; 5(2):a021444. PubMed ID: 25646384
[TBL] [Abstract][Full Text] [Related]
36. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
[TBL] [Abstract][Full Text] [Related]
37. Integrin α6 as an invasiveness marker for hepatitis B viral X-driven hepatocellular carcinoma.
Kim YR; Byun MR; Choi JW
Cancer Biomark; 2018; 23(1):135-144. PubMed ID: 30010110
[TBL] [Abstract][Full Text] [Related]
38. HBx-induced androgen receptor expression in HBV-associated hepatocarcinoma is independent of the methylation status of its promoter.
Zhu R; Zhang JS; Zhu YZ; Fan J; Mao Y; Chen Q; Zhu HG
Histol Histopathol; 2011 Jan; 26(1):23-35. PubMed ID: 21117024
[TBL] [Abstract][Full Text] [Related]
39. Viral co-factors in liver cancer: lessons from hepatitis B virus.
Butel JS; Lee TH; Slagle BL
Princess Takamatsu Symp; 1995; 25():185-98. PubMed ID: 8875624
[TBL] [Abstract][Full Text] [Related]
40. Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.
Tharayil VS; Roberts LR
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):387-406. PubMed ID: 17108869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
